XGenomes
PrivateLast Round
Seed
Sep 4, 2019
Total Funding Raised
$3.43M
Momentum Score
25 /100
Company Overview
XGenomes is a biotechnology company developing a next-generation DNA sequencing platform designed to be more accurate, rapid, and economical than existing technologies. The company's technology combines novel biochemistry, super-resolution single-molecule imaging, and artificial intelligence to decode DNA sequences and epigenetic modifications. Its mission is to enable lifelong health monitoring, early disease detection, and personalized treatment tracking by making its platform widely accessible. XGenomes was part of the Y Combinator Winter 2019 batch and has operations in Cambridge, MA, and Cambridge, UK.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XGenomes Comps
Public and private peers based on sector, stage, and business model.
XGenomes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 4, 2019 | ||||
| Grant | Sep 3, 2019 | ||||
| Grant | Jan 1, 2018 |
XGenomes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Cantos Ventures | Seed |
| Massachusetts Life Sciences Center | Grant |
| Amino Capital | Seed |
| The Engine | Seed |
| Y Combinator | Seed |
XGenomes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XGenomes's valuation, stock price, and market status.
